Suchergebnisse - "Bastianelli, Sabrina"

PubPharm (21)

1

Tixagevimab/Cilgavimab : Still a Valid Prophylaxis against COVID-19 New Variants?

enthalten in: Viruses | 2024

von Gidari, A. | Sabbatini, S. | Bastianelli, S. | +7

2

Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2023

von Schiaroli, E. | Gidari, A. | Brachelente, G. | +13

3

Remdesivir-Nirmatrelvir Combination: In Vitro Activity and a Case Report

enthalten in: Preprints.org | 2023

von Gidari, A. | Sabbatini, S. | Schiaroli, E. | +7

4

Synergistic Activity of Remdesivir-Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report

enthalten in: Viruses | 2023

von Gidari, A. | Sabbatini, S. | Schiaroli, E. | +7

5

Kaposi Sarcoma in People Living with HIV : Is it Water under the Bridge?

enthalten in: Mediterranean journal of hematology and infectious diseases | 2023

von Papalini, C. | Brescini, L. | Curci, L. | +4

6

Nelfinavir : An Old Ally in the COVID-19 Fight?

enthalten in: Microorganisms | 2022

von Gidari, A. | Sabbatini, S. | Pallotto, C. | +5

7

Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2

enthalten in: The Journal of infection | 2022

von Gidari, A. | Schiaroli, E. | Sabbatini, S. | +4

8

The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro

enthalten in: Microorganisms | 2022

von Gidari, A. | Sabbatini, S. | Schiaroli, E. | +10

9

The Combination of Molnupiravir with Nirmatrelvir or GC376 has a Synergic role in the Inhibition of SARS-CoV-2 Replication in Vitro

enthalten in: Preprints.org | 2022

von Gidari, A. | Sabbatini, S. | Schiaroli, E. | +10

10

Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria

enthalten in: Mediterranean journal of hematology and infectious diseases | 2022

von Schiaroli, E. | De Socio, G. | Gidari, A. | +10